Universal Ibogaine Inc. (IBO.V) Research

Universal Ibogaine Inc. is a life sciences enterprise that focuses on creating, obtaining, and managing addiction treatment centers throughout Canada. The company is also actively involved in scheduled clinical trials, researching the efficacy of ibogaine as a treatment for addiction. Its operations are directed from its head office in Calgary, Canada.

Market snapshot

Symbol
IBO.V
Price
$0.01
Day change
-50.00%
Market cap
$1.6M
P/E ratio
-4.16x
52-week range
0.005-0.045
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Captor Capital Corp. (CPTR.CN)
  • Entheon Biomedical Corp. (ENBI.CN)
  • Doseology Sciences Inc. (MOOD.CN)
  • Ovation Science Inc. (OVAT.CN)
  • Planet Based Foods Global Inc. (PBF.CN)
  • Premier Health of America Inc. (PHA.V)
  • Psyence Group Inc. (PSYG.CN)
  • RAMM Pharma Corp. (RAMM.CN)

Open Universal Ibogaine Inc. (IBO.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.